Innovation
13 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 159 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 3 |
Social engagement
Social engagement: 147 social following, 7 posts in the last 12 months — below the industry typical range.
Investor mix
8 investors on record; lead investors include Company K Partners, UTC Investment, Industrial Bank of Korea, KVIC.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 38% |
| Private equity | 1 | 13% |
| Other / undisclosed | 4 | 50% |
Recent activity
30 Apr 2026
Event
BIO KOREA 2026 Global VC Portfolio IR
2 Dec 2025
Event
2025 YONSEI PHARMA SYMPOSIUM
20 Nov 2025
Milestone
regulatory